Tell us how we can help
Clinician-to-clinician guidance
Coding, billing and reimbursement questions
Finding my sales representative
Support with an order
More than just reliably delivering nutritional products, we are also your clinical partner. This is why we are always working to advance the understanding and add to the growing body of clinical evidence around human milk. We are here with medical, clinical, economic and research support.
We are a group of leading registered dietitians who are passionate about human milk science and nutrition. After witnessing firsthand the improved patient outcomes of an Exclusive Human Milk Diet (EHMD) with neonatal patients, our mission is to enhance clinical practice, education, and outcomes in the Special Care Baby Unit (NICU) by sharing clinical expertise and emerging research.
Email: NAC@prolacta.com
As neonatal nurses and nurse practitioners, we have extensive clinical experience with mother’s own milk, donor milk, and human milk–based products. We are available to help you enhance clinical practice, education, and outcomes in your Special Care Baby Unit (NICU) by sharing our clinical expertise in the use of an Exclusive Human Milk Diet (EHMD).
Email: NPAC@prolacta.com
A growing body of clinical evidence supports the use of an Exclusive Human Milk Diet (EHMD), including Prolacta’s 100% human milk–based fortifiers, as a new standard of care for premature infants born weighing ≤1250 g.1,2,3,4 Enhanced protocols with earlier fortification using Prolacta’s fortifiers have been associated with achieving adequate growth,3,5,6 improved lung health,2,3 a lower risk of complications,7,8,9 reduced healthcare costs,1,10 and shorter Special Care Baby Unit (NICU) stays1 for infants receiving an Exclusive Human Milk Diet (EHMD).
This latest study by lead author Robert Huston, MD, published in the Journal of Neonatal-Perinatal Medicine,3 found that fortification with Prolacta’s 100% human milk–based fortifiers in the first days of life improves growth and reduces the risk of bronchopulmonary dysplasia (BPD) by 15% for infants receiving an Exclusive Human Milk Diet (EHMD), without the increased risk of complications seen with cow milk–based fortifiers.
The Huston et al (2020) early fortification study provides further data to support the practice of fortifying the human milk feedings of infants born at <1250 g birth weight with a 100% human milk–based fortifier at a lower feeding volume (<60 mL/kg/day) than has been a standard feeding practice in the past.
Clinician-to-clinician guidance
Coding, billing and reimbursement questions
Finding my sales representative
Support with an order